Literature DB >> 16001968

Characterization of a novel D2-like dopamine receptor with a truncated splice variant and a D1-like dopamine receptor unique to invertebrates from Caenorhabditis elegans.

Mai Sugiura1, Satoshi Fuke, Satoshi Suo, Noboru Sasagawa, Hubert H M Van Tol, Shoichi Ishiura.   

Abstract

We have cloned two novel Caenorhabditis elegans dopamine receptors, DOP-3 and DOP-4. DOP-3 shows high sequence homology with other D2-like dopamine receptors. As a result of alternative splicing, a truncated splice variant of DOP-3, DOP-3nf, was produced. Because of the in-frame insertion of a stop codon in the third intracellular loop, DOP-3nf lacks the sixth and seventh transmembrane domains that are found in the full-length DOP-3 receptor. Reporter gene assay showed that DOP-3 attenuates forskolin-stimulated cAMP formation in response to dopamine stimulation, whereas DOP-3nf does not. When DOP-3 was coexpressed with DOP-3nf, the ability to inhibit forskolin-stimulated cAMP formation was reduced. DOP-4 shows high sequence homology with D1-like dopamine receptors unique to invertebrates, which are distinct from mammalian D1-like dopamine receptors. Reporter gene assay showed that DOP-4 stimulates cAMP accumulation in response to dopamine stimulation. These two receptors provide new opportunities to understand dopaminergic signaling at the molecular level.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16001968     DOI: 10.1111/j.1471-4159.2005.03268.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  38 in total

Review 1.  Monoamines activate neuropeptide signaling cascades to modulate nociception in C. elegans: a useful model for the modulation of chronic pain?

Authors:  Rick Komuniecki; Gareth Harris; Vera Hapiak; Rachel Wragg; Bruce Bamber
Journal:  Invert Neurosci       Date:  2011-12-06

2.  Coexpressed D1- and D2-like dopamine receptors antagonistically modulate acetylcholine release in Caenorhabditis elegans.

Authors:  Andrew T Allen; Kathryn N Maher; Khursheed A Wani; Katherine E Betts; Daniel L Chase
Journal:  Genetics       Date:  2011-04-21       Impact factor: 4.562

Review 3.  Dopamine signaling architecture in Caenorhabditis elegans.

Authors:  Paul W McDonald; Tammy Jessen; Julie R Field; Randy D Blakely
Journal:  Cell Mol Neurobiol       Date:  2006-05-25       Impact factor: 5.046

4.  Multiple excitatory and inhibitory neural signals converge to fine-tune Caenorhabditis elegans feeding to food availability.

Authors:  Nicolas Dallière; Nikhil Bhatla; Zara Luedtke; Dengke K Ma; Jonathan Woolman; Robert J Walker; Lindy Holden-Dye; Vincent O'Connor
Journal:  FASEB J       Date:  2015-10-29       Impact factor: 5.191

Review 5.  Neurotransmitter signaling through heterotrimeric G proteins: insights from studies in C. elegans.

Authors:  Michael R Koelle
Journal:  WormBook       Date:  2018-12-11

6.  Neural Inhibition of Dopaminergic Signaling Enhances Immunity in a Cell-Non-autonomous Manner.

Authors:  Xiou Cao; Alejandro Aballay
Journal:  Curr Biol       Date:  2016-08-11       Impact factor: 10.834

7.  Dopamine counteracts octopamine signalling in a neural circuit mediating food response in C. elegans.

Authors:  Satoshi Suo; Joseph G Culotti; Hubert H M Van Tol
Journal:  EMBO J       Date:  2009-07-16       Impact factor: 11.598

8.  The C. elegans D2-like dopamine receptor DOP-3 decreases behavioral sensitivity to the olfactory stimulus 1-octanol.

Authors:  Meredith J Ezak; Denise M Ferkey
Journal:  PLoS One       Date:  2010-03-02       Impact factor: 3.240

9.  Dopamine suppresses octopamine signaling in C. elegans: possible involvement of dopamine in the regulation of lifespan.

Authors:  Satoshi Suo; Joseph G Culotti; Hubert H M Van Tol
Journal:  Aging (Albany NY)       Date:  2009-10-21       Impact factor: 5.682

10.  Stimulation of movement in a quiescent, hibernation-like form of Caenorhabditis elegans by dopamine signaling.

Authors:  Marta Maria Gaglia; Cynthia Kenyon
Journal:  J Neurosci       Date:  2009-06-03       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.